Back to Search
CAROLYN KRASNER, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1497767479IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
205759(MA)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
205759(MA)
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
205759(MA)
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 1995
Research & Publications (18)
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimens.
PMID 18000504·Br J Cancer·2007
3-trial
Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma.
PMID 11762415·Curr Pharm Biotechnol·2001
6-review
Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.
PMID 16611953·N Engl J Med·2006
8-other
Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.
PMID 19501233·J Allergy Clin Immunol·2009
8-other
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.
PMID 19332726·J Clin Oncol·2009
3-trial
Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
PMID 19058838·Gynecol Oncol·2009
3-trial
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.
PMID 19001330·J Clin Oncol·2008
3-trial
Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy.
PMID 17914739·Pediatr Blood Cancer·2008
5-case
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.
PMID 17561233·Gynecol Oncol·2007
5-case
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.
PMID 17245695·Psychooncology·2007
4-observational
Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.
PMID 16806439·Gynecol Oncol·2006
3-trial
Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
PMID 16566993·Gynecol Oncol·2006
3-trial
Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer.
PMID 16376743·J Pain Symptom Manage·2005
3-trial
Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
PMID 15863537·Obstet Gynecol·2005
4-observational
A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer.
PMID 15581974·Gynecol Oncol·2004
3-trial
Phase I trial of escalating doses of topotecan in combination with a fixed dose of pegylated liposomal doxorubicin in women with müllerian malignancies.
PMID 15196868·Gynecol Oncol·2004
3-trial
Detection of Staphylococcus aureus in peripheral blood stem cell cultures after sterilization of standard blood cultures.
PMID 12717792·J Clin Apher·2003
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 55 FRUIT STREET YAW 9, GILLETTE CENTER FOR WOMEN'S CANCER
BOSTON, MA 02114 - Phone
- (617) 724-3200
Quick Facts
- NPI
- 1497767479
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 31
- Publications
- 18
Are you this provider?
Claim Your Profile